Mont. Code § 50-12-102

Current through the 2023 Regular Session

Section 50-12-102 - Definitions

As used in this part, the following definitions apply:

(1) "Health care facility" has the meaning provided in 50-5-101.

(2) "Health care provider" means any of the following individuals licensed pursuant to Title 37:

(a) a physician;

(b) an advanced practice registered nurse authorized by the board of nursing to prescribe medicine; and

(c) a physician assistant.

(3) "Investigational drug, biological product, or device" means a drug, biological product, or device that:

(a) has successfully completed phase 1 of a clinical trial but has not yet been approved for general use by the United States food and drug administration; and

(b) remains under investigation in a United States food and drug administration-approved clinical trial.

(4) "Written informed consent" means a written document that meets the requirements of 50-12-105.

§ 50-12-102, MCA

Amended by Laws 2023, Ch. 413,Sec. 1, eff. 10/1/2023.

Amended by Laws 2023, Ch. 88,Sec. 14, eff. 4/18/2023.

Added by Laws 2015, Ch. 135, Sec. 2, eff. 3/27/2015.